Skip to content
Screener

Stock-Based Comp at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$44M+120%
Mannkind logo
MannkindMNKD
$10.23M+36.0%
United Therapeutics logo
United TherapeuticsUTHR
$43.4M+14.8%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$30.57M+65.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$4.5M-7.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$33.24M+28.4%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating activities
Net income (loss)$52,862$(38,367)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation9,2177,438
Depreciation and amortization497451
Non-cash lease expense(409)55
Accretion and non-cash interest expense6,4944,670
Changes in operating assets and liabilities:

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's stock-based comp?
Liquidia Corporation (LQDA) reported stock-based comp of $9.22M in Q1 2026.
How has Liquidia Corporation's stock-based comp changed year-over-year?
Liquidia Corporation's stock-based comp increased by 23.9% year-over-year, from $7.44M to $9.22M.
What is the long-term trend for Liquidia Corporation's stock-based comp?
Over 4 years (2021 to 2025), Liquidia Corporation's stock-based comp has grown at a 44.6% compound annual growth rate (CAGR), from $6.75M to $29.47M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Liquidia Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude